Skip to content
10-Q

Quarterly Report

ASTEX PHARMACEUTICALS, INC

0001047469-13-005895

← back to feed
Filed
May 10, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 3, 2013 94.6M sh
Shares Diluted Q1 2013 · Mar 31, 2013 96.8M sh
Shares Diluted Q1 2013 · Mar 31, 2012 103.99M sh
Capex Q1 2013 · Mar 31, 2013 $291K
Capex Q1 2013 · Mar 31, 2012 $668K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $61.73M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $15.5M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $34.68M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $39.79M
Stockholders Equity Q1 2013 · Mar 31, 2013 $233.12M
Stockholders Equity Q1 2013 · Dec 31, 2012 $236.94M
Current Liabilities Q1 2013 · Mar 31, 2013 $31.19M
Current Liabilities Q1 2013 · Dec 31, 2012 $19.64M
Total Liabilities Q1 2013 · Mar 31, 2013 $32.96M
Total Liabilities Q1 2013 · Dec 31, 2012 $38.22M
Current Assets Q1 2013 · Mar 31, 2013 $146.73M
Current Assets Q1 2013 · Dec 31, 2012 $146.51M
Total Assets Q1 2013 · Mar 31, 2013 $266.08M
Total Assets Q1 2013 · Dec 31, 2012 $275.16M
Eps Diluted Q1 2013 · Mar 31, 2013 $0.01
Eps Diluted Q1 2013 · Mar 31, 2012 $0.04
Eps Basic Q1 2013 · Mar 31, 2013 $0.01
Eps Basic Q1 2013 · Mar 31, 2012 $0.05
Sga Expense Q1 2013 · Mar 31, 2013 $4.14M
Sga Expense Q1 2013 · Mar 31, 2012 $4.34M
Rd Expense Q1 2013 · Mar 31, 2013 $17.87M
Rd Expense Q1 2013 · Mar 31, 2012 $14.07M
Operating Income Q1 2013 · Mar 31, 2013 −$1.82M
Operating Income Q1 2013 · Mar 31, 2012 $1.46M
Revenue Q1 2013 · Mar 31, 2013 $22.09M
Revenue Q1 2013 · Mar 31, 2012 $22.02M